Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
BMRI.JK Stock Summary
In the News
BMRI.JK Financial details
Company Rating
Strong Buy
Market Cap
630630B
Income
55060.06B
Revenue
123222.38B
Book val./share
2794.85
Cash/share
2630.34
Dividend
264.67
Dividend %
4.12%
Employees
38.97K
Optionable
No
Shortable
Yes
Earnings
16 Apr 2024
P/E
40.29
Forward P/E
-
PEG
11.95
P/S
6.51
P/B
8.21
P/C
2.56
P/FCF
-17.29
Quick Ratio
30.13
Current Ratio
30.13
Debt / Equity
0.97
LT Debt / Equity
0.51
-
-
EPS (TTM)
590.04
EPS next Y
-
EPS next Q
-
EPS this Y
33.69%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
14.91%
Revenue last 5Y
6.21%
Revenue Q/Q
1.99%
EPS Q/Q
15.65%
-
-
-
-
SMA20
-4.68%
SMA50
4.76%
SMA100
16.29%
Inst Own
-
Inst Trans
-
ROA
2%
ROE
22%
ROC
0.04%
Gross Margin
100%
Oper. Margin
83%
Profit Margin
54%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
4950.0-7500.0
52W High
-10.33%
52W Low
+35.86%
RSI
41.39
Rel Volume
0.17
Avg Volume
103.49M
Volume
18.11M
Perf Week
-2.54%
Perf Month
-4.61%
Perf Quarter
-
Perf Half Y
12.08%
-
-
-
-
Beta
0.591
-
-
Volatility
89.64%, 201.63%
Prev Close
-1.1%
Price
6725
Change
-1.1%
BMRI.JK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 976.74 | 986.34 | 1.21K | 0.24 | 1.32K | |
Net income per share | 294.45 | 180.13 | 300.53 | 441.26 | 589.93 | |
Operating cash flow per share | 256.8 | 1.09K | 1.39K | 1.08K | -745.96 | |
Free cash flow per share | 205 | 1.04K | 1.34K | 1K | -819.83 | |
Cash per share | 1.34K | 1.91K | 2.1K | 2.98K | 2.63K | |
Book value per share | 2.19K | 2.03K | 2.19K | 2.46K | 2.79K | |
Tangible book value per share | 2.2K | 2.02K | 2.32K | 2.65K | 21.67K | |
Share holders equity per share | 2.19K | 2.03K | 2.19K | 2.46K | 2.79K | |
Interest debt per share | 1.74K | 1.67K | 1.82K | 2K | 3.03K | |
Market cap | 358166.67B | 294942.76B | 327584.65B | 463014.72B | 571666.67B | |
Enterprise value | 317918.72B | 205301.19B | 225844.6B | 292312.2B | 472346.91B | |
P/E ratio | 13.03 | 17.56 | 11.69 | 11.25 | 10.38 | |
Price to sales ratio | 3.93 | 3.21 | 2.91 | 20.99K | 4.64 | |
POCF ratio | 14.94 | 2.89 | 2.52 | 4.6 | -8.21 | |
PFCF ratio | 18.72 | 3.05 | 2.61 | 4.95 | -7.47 | |
P/B Ratio | 1.75 | 1.56 | 1.6 | 2.02 | 2.19 | |
PTB ratio | 1.75 | 1.56 | 1.6 | 2.02 | 2.19 | |
EV to sales | 3.49 | 2.23 | 2.01 | 13.25K | 3.83 | |
Enterprise value over EBITDA | 8.47 | 7.76 | 5.73 | 3.77 | 6.36 | |
EV to operating cash flow | 13.26 | 2.01 | 1.74 | 2.9 | -6.78 | |
EV to free cash flow | 16.62 | 2.12 | 1.8 | 3.13 | -6.17 | |
Earnings yield | 0.08 | 0.06 | 0.09 | 0.09 | 0.1 | |
Free cash flow yield | 0.05 | 0.33 | 0.38 | 0.2 | -0.13 | |
Debt to equity | 0.65 | 0.67 | 0.73 | 0.72 | 0.97 | |
Debt to assets | 0.1 | 0.09 | 0.09 | 0.08 | 0.12 | |
Net debt to EBITDA | -1.07 | -3.39 | -2.58 | -2.2 | -1.34 | |
Current ratio | 71.05 | 56.13 | 89.28 | 40.14 | 0.23 | |
Interest coverage | 1.22 | 0.81 | 1.75 | 3.56 | 2.27 | |
Income quality | 0.87 | 6.08 | 4.63 | 2.45 | -1.26 | |
Dividend Yield | 0.03 | 0.06 | 0.03 | 0.04 | 0.04 | |
Payout ratio | 0.41 | 0.98 | 0.37 | 0.41 | 0.45 | |
Sales general and administrative to revenue | 0.13 | 0.12 | 0.12 | 637.38 | 0.12 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.2 | -0.05 | -0.04 | -0.07 | 0.1 | |
Capex to revenue | -0.05 | -0.06 | -0.04 | -327.64 | -0.06 | |
Capex to depreciation | -2.35 | -1.33 | -1.29 | -1.6 | -1.51 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 3.81K | 2.87K | 3.85K | 4.94K | 6.09K | |
ROIC | 0.08 | 0.05 | 0.08 | 0.15 | 0.11 | |
Return on tangible assets | 0.02 | 0.01 | 0.02 | 0.02 | 0.03 | |
Graham Net | -11.18K | -12.56K | -15.15K | -17.14K | -527.98 | |
Working capital | 164372.96B | 219719.78B | 236723.33B | 322004.95B | 919131.12B | |
Tangible asset value | 205713.24B | 189275.46B | 216999.52B | 247151.85B | 2022166.46B | |
Net current asset value | 942492.42B | 1011833.34B | 1264095.14B | 1410067.27B | 125864.58B | |
Invested capital | 0.65 | 0.67 | 0.73 | 0.72 | 0.97 | |
Average receivables | 39976.69B | 43823.49B | 44435.72B | 47807.48B | 39464.1B | |
Average payables | 2203.96B | 3165.85B | 3333.33B | 5454.2B | 4631.49B | |
Average inventory | 90542.09B | 238526.52B | 286162.63B | 314174.13B | 344502.78B | |
Days sales outstanding | 168.19 | 181.09 | 140.13 | 866.88K | 78.62 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 2.17 | 2.02 | 2.6 | 0 | 4.64 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.13 | 0.09 | 0.14 | 0.18 | 0.21 | |
Capex per share | -51.8 | -56.02 | -49.26 | -77.45 | -73.87 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.07 | 313.31 | 328.31 | 336.08 | 342.78 | |
Net income per share | 112.78 | 134.68 | 135.77 | 148.2 | 171.39 | |
Operating cash flow per share | 997.65 | -966.07 | -173.1 | -159.05 | 551.52 | |
Free cash flow per share | 964.89 | -974.63 | -183.27 | -174.93 | 512.27 | |
Cash per share | 2.98K | 2.02K | 2.1K | 2.07K | 2.63K | |
Book value per share | 2.46K | 2.33K | 2.48K | 2.61K | 2.79K | |
Tangible book value per share | 2.65K | 2.54K | 2.68K | 2.82K | 21.67K | |
Share holders equity per share | 2.46K | 2.33K | 2.48K | 2.61K | 2.79K | |
Interest debt per share | 1.84K | 1.82K | 2.45K | 2.46K | 2.79K | |
Market cap | 462815.32B | 481467.83B | 485333.33B | 562333.33B | 571666.67B | |
Enterprise value | 292112.8B | 401487.41B | 425997.75B | 506500.38B | 472346.91B | |
P/E ratio | 11 | 9.58 | 9.58 | 10.16 | 8.93 | |
Price to sales ratio | 75.57K | 16.48 | 15.84 | 17.93 | 17.87 | |
POCF ratio | 4.97 | -5.34 | -30.04 | -37.88 | 11.11 | |
PFCF ratio | 5.14 | -5.3 | -28.37 | -34.44 | 11.96 | |
P/B Ratio | 2.02 | 2.21 | 2.1 | 2.31 | 2.19 | |
PTB ratio | 2.02 | 2.21 | 2.1 | 2.31 | 2.19 | |
EV to sales | 47.7K | 13.74 | 13.9 | 16.15 | 14.76 | |
Enterprise value over EBITDA | 14.12 | 16.67 | 24.87 | 27.21 | 21.97 | |
EV to operating cash flow | 3.14 | -4.46 | -26.37 | -34.12 | 9.18 | |
EV to free cash flow | 3.25 | -4.42 | -24.9 | -31.02 | 9.88 | |
Earnings yield | 0.02 | 0.03 | 0.03 | 0.02 | 0.03 | |
Free cash flow yield | 0.19 | -0.19 | -0.04 | -0.03 | 0.08 | |
Debt to equity | 0.72 | 0.75 | 0.96 | 0.91 | 0.97 | |
Debt to assets | 0.08 | 0.09 | 0.11 | 0.11 | 0.12 | |
Net debt to EBITDA | -8.25 | -3.32 | -3.46 | -3 | -4.62 | |
Current ratio | 40.14 | 23.8 | 25.07 | 30.13 | 0.23 | |
Interest coverage | 3.18 | 3.26 | 2.27 | 2.26 | 2.29 | |
Income quality | 8.85 | -7.17 | -1.27 | -1.07 | 3.22 | |
Dividend Yield | 0 | 0 | 0.05 | 0 | 0 | |
Payout ratio | 0 | 0 | 1.95 | 0 | 0 | |
Sales general and administrative to revenue | 811.7 | 0.1 | 0.1 | 0.12 | 0.14 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.03 | 0.01 | 0.06 | 0.1 | -0.07 | |
Capex to revenue | -498.82 | -0.03 | -0.03 | -0.05 | -0.11 | |
Capex to depreciation | -2.19 | -0.76 | -0.85 | -1.37 | -2.79 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 2.5K | 2.66K | 2.75K | 2.95K | 3.28K | |
ROIC | 0.04 | 0.05 | 0.03 | 0.03 | 0.03 | |
Return on tangible assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Graham Net | -17.15K | -16.84K | -17.32K | -17.61K | -527.98 | |
Working capital | 322004.95B | 232993.52B | 231475.53B | 230990.03B | 919131.12B | |
Tangible asset value | 247151.85B | 236621.47B | 250187.66B | 263508.58B | 2022166.46B | |
Net current asset value | 1410067.27B | 1423312.04B | 1467649.42B | 1499414.27B | 125864.58B | |
Invested capital | 0.72 | 0.75 | 0.96 | 0.91 | 0.97 | |
Average receivables | 51224.64B | 53670.22B | 50183.81B | 45494.38B | 36061.52B | |
Average payables | 7095.13B | 9223.58B | 9918.05B | 8773.43B | 4483.44B | |
Average inventory | 302087.33B | 309750.72B | 271533.55B | 270283.8B | 301011.88B | |
Days sales outstanding | 769.84K | 169.27 | 133.38 | 130.77 | 74.67 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0.53 | 0.67 | 0.69 | 1.21 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.05 | 0.06 | 0.05 | 0.06 | 0.06 | |
Capex per share | -32.75 | -8.56 | -10.17 | -15.89 | -39.25 |
BMRI.JK Frequently Asked Questions
What is PT Bank Mandiri (Persero) Tbk stock symbol ?
PT Bank Mandiri (Persero) Tbk is a ID stock and trading under the symbol BMRI.JK
What is PT Bank Mandiri (Persero) Tbk stock quote today ?
PT Bank Mandiri (Persero) Tbk stock price is $6725 today.
Is PT Bank Mandiri (Persero) Tbk stock public?
Yes, PT Bank Mandiri (Persero) Tbk is a publicly traded company.